EPRX EUPRAXIA PHARMACEUTICALS INC.
Price Chart
Executive Summary
Eupraxia Pharmaceuticals filed a 6-K announcing management's participation in the Jefferies Global Healthcare Conference on June 3-4, 2026. The filing contains no new clinical data, financial results, or material corporate developments — it is a routine investor conference announcement.
Actionable Insight
This is a routine conference participation announcement with no material news. Monitor the conference webcast on June 3 for any pipeline updates or commentary, but no immediate trading catalyst is present.
Key Facts
- Eupraxia management will present at the Jefferies Global Healthcare Conference on June 3, 2026, from 5:30-6:00 PM ET.
- 1x1 investor meetings are scheduled for June 3 and 4, 2026.
- The filing includes no new clinical data, financial guidance, or material business updates.
- The company is a clinical-stage biotech with EP-104GI in Phase 1b/2 (RESOLVE trial for EoE) and a completed Phase 2b (SPRINGBOARD) for knee osteoarthritis pain.
Financial Impact
No financial figures disclosed in the filing.
Risk Factors
- No new clinical data or financial updates — stock may drift on sector sentiment.
- Conference participation alone rarely moves stock price without accompanying data or guidance.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003762 |
| Exhibit: exh_991.htm | 0001171843-26-003762 |
| Document: 0001171843-26-003762-index-headers.html | 0001171843-26-003762 |
| Document: 0001171843-26-003762-index.html | 0001171843-26-003762 |
| Document: 0001171843-26-003762.txt | 0001171843-26-003762 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 29, 2026
16d ago
|
6-K
| $7.09 $6.33 | ▼ −10.72% | ▼ −10.43% | $6.04 (−14.81%) |
|
May 29, 2026
16d ago
|
6-K
| $7.09 $6.33 | ▼ −10.72% | ▼ −10.43% | $6.04 (−14.81%) |
|
May 28, 2026
17d ago
|
6-K
| $7.09 $5.95 | ▼ −16.08% | ▼ −13.56% | $6.04 (−14.81%) |
|
May 12, 2026
4w ago
|
Press Release
| $7.55 $6.29 | ▲ +16.69% | ▲ +15.53% | $6.04 (+20.00%) |
|
Apr 22, 2026
7w ago
|
6-K
| $7.06 $7.11 | ▲ +0.71% | ▲ +0.65% | $6.04 (−14.45%) |
|
Apr 21, 2026
7w ago
|
6-K
| $7.02 $7.11 | ▲ +1.28% | ▲ +0.20% | $6.04 (−13.96%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $7.02 $7.11 | ▲ +1.28% | ▲ +0.20% | $6.04 (−13.96%) |
|
Mar 13, 2026
13w ago
|
Press Release
| $7.36 $7.10 | ▼ −3.53% | ▼ −1.41% | $6.04 (−17.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access